Chief Executive Officer & Co-Founder
As a researcher in Toronto, Acorn founder Dr Drew Taylor saw an urgent need to prepare our younger cells for the future of medicine. He struggled to accept the scenario where we have to tell patients “Yes there are stem cell therapies available for your condition but unfortunately, your cells are too old and damaged to be leveraged”. To help change this he founded Acorn Biolabs in 2017.
Prior to founding Acorn, Drew spent several years as Chief Science Officer at Epic Capital Management working across the flourishing biotech start-up community. Previous to his role at Epic Capital, Drew spent time as part of the Mount Sinai Hospital Bioengineering of Skeletal Tissues Team.
Drew Taylor completed his undergraduate and Master’s degree in Molecular, Cellular, Developmental Biology at the University of Michigan and went on to complete a PhD in Biomedical Engineering from the University of Toronto.
Drew has also enjoyed a successful career in professional minor league baseball as a pitcher for both the Toronto Blue Jays and the Philadelphia Phillies, charting parallel paths across both professional sports and science.